Strategic alliance Leveraging Kerry Group ownership and the integrated Kerry Biotechnology Centre to position c-LEcta as a preferred partner for co-developed enzyme solutions across food, feed, beverage, and pharma, enabling joint go-to-market and larger deal opportunities.

Global fermentation capabilities Capitalize on over two decades of enzyme engineering and production know-how to offer end-to-end services from discovery to production, appealing to clients seeking fully integrated bioprocess development under one roof.

Quality and compliance Highlight ISO 9001 certified quality management since 2011 and established regulatory readiness to attract customers in regulated markets such as food and pharma, easing supplier qualification for large accounts.

Innovation footprint Position the 80+ strong team of scientists and innovation experts as a differentiator for next-generation enzyme solutions, targeting customers pursuing performance gains, sustainability improvements, and novel biotechnological applications.

Growth and exposure Use Kerry Group acquisition and ongoing research center activities to pursue expansion into new regional markets and industries, offering co-investment and licensing opportunities to broaden the customer base and revenue streams.